We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Karen Gelmon

Karen Gelmon MD

Medical Oncologist, Department of Medical Oncology, British Columbia Cancer Agency; Professor of Medicine, University of British Columbia, Vancouver, British Columbia

Dr. Karen Gelmon is a Professor of Medicine at the University of British Columbia and a Medical Oncologist at the British Columbia Cancer Agency (BCCA), combining clinical and translational research. She is Co-Chair of the Breast Site Committee for the NCIC Clinical Trials Group (CTG) and a member of the NCI Breast Steering Committee and of the BIG (Breast International Group) Advisory Group. She sits on the NCIC-CTG IND Executive Committee and is a past Chair of this committee. She is also a Komen Scholar and member of the Scientific Advisory Council for Komen. She is Co-Chair of the Scientific Advisory Council of the Ontario Institute of Cancer Research. She is Clinical Leader of the Advanced Therapeutics department at the BCCA.

 

Dr. Gelmon is an active teacher, interested in education of healthcare professionals and the public; she has published extensively. She sits on the International Advisory Board of The Lancet, The Oncologist, and Clinical Breast Cancer. She has been Chair for the Breast Cancer Track at ASCO and is currently on the Education Committee. She has been a member of the board of the British Columbia Cancer Foundation and the Medical Advisory Board of the British Columbia/Yukon Chapter of the Canadian Breast Cancer Foundation, and currently sits on the board of Rethink Breast Cancer.

 

In 2003, Dr. Gelmon was the recipient of a YWCA Woman of Distinction award. She is the mother of two daughters and is active on volunteer boards for the arts and community in Vancouver.

Recent Contributions to PracticeUpdate:

  1. Targets and Targeted Therapy in Breast Cancer